| 000 | 01883 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516225103.0 | ||
| 264 | 0 | _c20151117 | |
| 008 | 201511s 0 0 eng d | ||
| 022 | _a1532-8511 | ||
| 024 | 7 |
_a10.1016/j.jstrokecerebrovasdis.2014.02.013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChausson, Nicolas | |
| 245 | 0 | 0 |
_aInfarction in the anterior choroidal artery territory: clinical progression and prognosis factors. _h[electronic resource] |
| 260 |
_bJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association _cSep 2014 |
||
| 300 |
_a2012-2017 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aCerebral Arteries _xpathology |
| 650 | 0 | 4 |
_aCerebral Infarction _xdiagnosis |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xepidemiology |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aThrombolytic Therapy |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xtherapeutic use |
| 700 | 1 | _aJoux, Julien | |
| 700 | 1 | _aSaint-Vil, Martine | |
| 700 | 1 | _aEdimonana, Mireille | |
| 700 | 1 | _aJeannin, Séverine | |
| 700 | 1 | _aAveillan, Mathieu | |
| 700 | 1 | _aCabre, Philippe | |
| 700 | 1 | _aOlindo, Stéphane | |
| 700 | 1 | _aSmadja, Didier | |
| 773 | 0 |
_tJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association _gvol. 23 _gno. 8 _gp. 2012-2017 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jstrokecerebrovasdis.2014.02.013 _zAvailable from publisher's website |
| 999 |
_c24066545 _d24066545 |
||